GSK raises £885.6m from Haleon share sale
GSK
1,284.00p
14:45 15/11/24
-5.13%
-69.50p
GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.
FTSE 100
8,066.82
14:45 15/11/24
n/a
n/a
FTSE 350
4,456.83
14:45 15/11/24
n/a
n/a
FTSE All-Share
4,415.08
14:45 15/11/24
n/a
n/a
Haleon
364.10p
14:45 15/11/24
0.58%
2.10p
Pharmaceuticals & Biotechnology
19,173.57
14:45 15/11/24
-3.14%
-621.39
The company sold the shares in a placing to institutional investors at 328p each.
Following the settlement of the placing, GSK will hold 685m ordinary shares in Haleon, which represents a stake of 7.4%.
GSK and Pfizer, which has a 32% interest in Haleon, have each undertaken not to dispose of any further shares in Haleon for 60 days following settlement of the placing.